|
Lorenzo M, Jacobs-Cacha C, Palau P, Amiguet M, Seller J, Nunez E, Espriella R, Gorriz JL, Minana G, Sanchis J, Bayes-Genis A, Soler MJ, Packer M, Nunez J; DAPA-VO2 Investigators. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status. JACC Heart Fail. 2023 Nov;11(11):1611-1622. doi: 10.1016/j.jchf.2023.07.010. Epub 2023 Sep 6. PubMed PMID: 37676213.
AÑO: 2023; IF: 10.3
|
|
Lax A., Soler F., Fernandez del Palacio M.J., Pascual-Oliver S., Ballester M.R., Fuster J.J., Pascual-Figal D., Asensio-Lopez M.d.C. Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis. Molecular Therapy Nucleic Acids. 13 June 2023. 32:704-720. 10.1016/j.omtn.2023.04.031
AÑO: 2023; IF: 6.5
|
|
Pascual-Figal D, Lax A, Asensio Lopez MC. Circulating ST2, from biomarker to pathogenic mediator. Rev Esp Cardiol (Engl Ed). 2023 Sep;76(9):672-674. doi: 10.1016/j.rec.2023.02.012. Epub 2023 Apr 19. No abstract available. English, Spanish. PubMed PMID: 37085116.
AÑO: 2023; IF: 5.9
|
|
Vicent L., Álvarez-García J., Vazquez-Garcia R., González-Juanatey J.R., Rivera M., Segovia J., Pascual-Figal D., Bover R., Worner F., Fernández-Avilés F., Ariza-Sole A., Martínez-Sellés M. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction. Journal of Clinical Medicine. April 2023. 12. 10.3390/jcm12083028
AÑO: 2023; IF: 3.0
|
|
Lopez-Palop R, Carrillo P, Leithold G, Lozano I, Nieto A, Frutos A, Garcia J, Freites A, Lacunza J, Duran JM, Hurtado J, Gimeno JR, Valdesuso R, Pinar E, Pascual D. Accuracy of the angiography-based quantitative flow ratio in intermediate left main coronary artery lesions and comparison with visual estimation. Int J Cardiol. 2023 Jul 15;383:8-14. doi: 10.1016/j.ijcard.2023.04.035. Epub 2023 Apr 20. PubMed PMID: 37085119.
AÑO: 2023; IF: 3.2
|